glp 1 dual agonist GIP/GLP-1 receptor agonists: New advances for treating type-2 diabetes New Weight-Loss Drugs Are Poised

The company has three drug candidates in clinical development for ophthalmic, cardiac, and dermal indications , with RGN-259 receiving orphan drug designation for neurotrophic keratopathy

Although the primary endpoint was not achieved, secondary endpoints and exploratory analyses suggest that participants with TNFi-IR PsA, particularly those with elevated CRP, could derive clinically meaningful benefits with guselkumab and golimumab combination therapy, with no new safety concerns, warranting further investigation, the researchers wrote

In individuals with normal B12 metabolism and no ongoing deficiency, the body's stores can theoretically last several years

Metabolic studies Animals were given either 6 g/kg glucose or distilled water (2 mL/100 g body weight, n = 10 for all groups) by gavage every 6 h (at 06:20, 12:20, 18:20, and 24:20 h) for 38 days, defined as the long-term oscillating glucose (LOsG) or sham group